Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6836693Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$448.8K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#33,952
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Kunwar Shailubhai as a PI. Multi-PI records show the full award amount for context.
- 1R43DK141298-01A1R43Combination of formulated dolcanatide, a guanylate cyclase-C agonist, with formulated atiprimod, a JAK-STAT inhibitor, for treatment of murine colitis.$358Kaward amount
- 5R43CA291267-02R43Microsphere-based formulation of dolcanatide to prevent colon carcinogenesis$90.7Kaward amount
Award organization
Organizations that administered FY2025 awards listing Kunwar Shailubhai as a PI.
FY2025 award administered by Nous Biosciences Inc (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNous Biosciences Inc
- 2025$500K Cumulative Funding